REGARDING RECENTLY PUBLISHED ARTICLE ON SAFETY AND EFFICACY OF AMINOLEVULINIC ACID 10% TOPICAL GEL VERSUS AMINOLEVULINIC ACID 20% TOPICAL SOLUTION FOLLOWED BY BLUE-LIGHT PHOTODYNAMIC THERAPY FOR TREATMENT OF ACTINIC KERATOSIS

Documenti analoghi

• Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study
  di: Nestor, Mark S., et al.
  Pubblicazione: (2019)
• Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up
  di: Ko, Dong-Yeob, et al.
  Pubblicazione: (2014)
• Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy
  di: Kanick, SC, et al.
  Pubblicazione: (2015)
• Topical treatments and photodynamic therapy for actinic keratosis of the face and scalp
  di: Foley, Kelly, et al.
  Pubblicazione: (2019)
• Equivalent efficacy of indoor daylight and lamp‐based 5‐aminolevulinic acid photodynamic therapy for treatment of actinic keratosis
  di: Alberto J. Ruiz, et al.
  Pubblicazione: (2023-08-01)